Viewing Study NCT03527108


Ignite Creation Date: 2025-12-26 @ 10:57 AM
Ignite Modification Date: 2025-12-31 @ 5:46 PM
Study NCT ID: NCT03527108
Status: RECRUITING
Last Update Posted: 2025-07-04
First Post: 2018-05-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLC
Sponsor: Fox Chase Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module